Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
1.100
-0.040 (-3.51%)
At close: Nov 22, 2024, 4:00 PM
1.110
+0.010 (0.91%)
After-hours: Nov 22, 2024, 5:46 PM EST
Genprex Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 11.41 | 13.44 | 12.3 | 11.68 | 10.64 | 8.7 | |
Research & Development | 11.41 | 17.62 | 11.51 | 8.97 | 7.3 | 1.97 | |
Operating Expenses | 22.83 | 31.08 | 23.83 | 20.67 | 17.96 | 10.68 | |
Operating Income | -22.83 | -31.08 | -23.83 | -20.67 | -17.96 | -10.68 | |
Interest & Investment Income | 0.1 | 0.22 | 0.09 | 0.01 | 0.02 | 0.03 | |
Pretax Income | -22.71 | -30.86 | -23.74 | -20.66 | -17.94 | -10.65 | |
Net Income | -22.71 | -30.86 | -23.74 | -20.66 | -17.94 | -10.65 | |
Net Income to Common | -22.71 | -30.86 | -23.74 | -20.66 | -17.94 | -10.65 | |
Shares Outstanding (Basic) | 2 | 1 | 1 | 1 | 1 | 0 | |
Shares Outstanding (Diluted) | 2 | 1 | 1 | 1 | 1 | 0 | |
Shares Change (YoY) | 69.48% | 14.09% | 1.82% | 32.58% | 121.64% | 16.38% | |
EPS (Basic) | -10.34 | -22.56 | -19.80 | -17.55 | -20.20 | -26.59 | |
EPS (Diluted) | -10.34 | -22.56 | -19.80 | -17.55 | -20.20 | -26.59 | |
Free Cash Flow | -18.24 | -24.74 | -17.62 | -14.32 | -13.95 | -6.95 | |
Free Cash Flow Per Share | -8.31 | -18.09 | -14.70 | -12.16 | -15.71 | -17.35 | |
EBITDA | -22.82 | -31.06 | -23.81 | -20.65 | -17.94 | -10.67 | |
D&A For EBITDA | 0.01 | 0.02 | 0.03 | 0.02 | 0.02 | 0.01 | |
EBIT | -22.83 | -31.08 | -23.83 | -20.67 | -17.96 | -10.68 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.